statistiche ricercatore

Continente	#
NA - Nord America	555
AS - Asia	368
EU - Europa	253
SA - Sud America	61
AF - Africa	25
Continente sconosciuto - Info sul continente non disponibili	23
Totale	1.285

Nazione	#
US - Stati Uniti d'America	533
SG - Singapore	147
CN - Cina	84
VN - Vietnam	63
IT - Italia	58
BR - Brasile	43
IE - Irlanda	41
DE - Germania	36
SE - Svezia	31
HK - Hong Kong	24
FI - Finlandia	23
RU - Federazione Russa	17
ZA - Sudafrica	16
TR - Turchia	12
FR - Francia	11
BD - Bangladesh	10
CA - Canada	10
NL - Olanda	10
AR - Argentina	7
GB - Regno Unito	7
MX - Messico	7
IN - India	5
PH - Filippine	5
AT - Austria	4
BE - Belgio	4
CZ - Repubblica Ceca	4
KR - Corea	4
EC - Ecuador	3
KE - Kenya	3
PL - Polonia	3
TH - Thailandia	3
AE - Emirati Arabi Uniti	2
CI - Costa d'Avorio	2
CO - Colombia	2
CR - Costa Rica	2
ID - Indonesia	2
JP - Giappone	2
MA - Marocco	2
VE - Venezuela	2
AO - Angola	1
BO - Bolivia	1
CG - Congo	1
CL - Cile	1
CW - ???statistics.table.value.countryCode.CW???	1
DK - Danimarca	1
EE - Estonia	1
ES - Italia	1
EU - Europa	1
IQ - Iraq	1
JO - Giordania	1
KZ - Kazakistan	1
LT - Lituania	1
NI - Nicaragua	1
PK - Pakistan	1
PR - Porto Rico	1
PY - Paraguay	1
SV - El Salvador	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	1.264

Nome	#
Prognostic role of mesenteric lymph nodes involvent in patients undergoing posterior pelvic exeteration during radical or supra-radical surgery for advanced ovarían cancer	222
Do Exophytic and Endophytic Patterns in Borderline Ovarian Tumors Have Different Prognostic Implications? A Large Multicentric Experience.	173
MESENTERIC LYMPHNODE INVOLVEMENT IN ADVANCED OVARIAN CANCER.	168
Posterior pelvic exenteration and retrograde total hysterectomy in patients with locally advanced ovarian cancer: Clinical and functional outcome	167
Obesity, an independent predictor of pre and postoperative tumor grading disagreement in endometrial cancer	157
Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single institution experience	156
ABSOLUTE DEPTH OF INVASION, TUMOR FREE DISTANCE AND MYOMETRIAL INVASION: WHICH IS THE BEST PREDICTING FACTOR FOR NODAL INVOLVEMENT AND RECURRENCE IN ENDOMETRIAL CANCER?	152
A randomized controlled trial on the oncologic outcomes of use of the intrauterine manipulator in the treatment of apparent uterine-confined endometrial carcinoma: the MANEC Trial	90
Totale	1.285

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	22	0	0	0	0	1	0	1	1	1	0	1	17
2022/2023	171	15	23	16	16	13	22	0	9	45	0	6	6
2023/2024	79	2	11	1	6	2	23	2	6	1	7	8	10
2024/2025	243	9	9	24	19	22	19	7	12	41	16	14	51
2025/2026	524	72	29	54	55	73	45	47	21	63	42	13	10
2026/2027	99	11	18	27	43	0	0	0	0	0	0	0	0
Totale													1.285